Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.68 |
| ▸ | HTT | P42858 | 3/20 | 0.68 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | IDO1 | P14902 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL69791 | 0.84 | HTT (0.69) | KMT2AHTTTSHRALDH1A1KDM4E | |
| SCHEMBL21981938 | 0.82 | HTT (0.67) | KMT2AHTTTSHRALDH1A1KDM4E | |
| SCHEMBL29390370 | 0.82 | KMT2A (0.50) | KMT2AHTTTSHRGLAALDH1A1 | |
| Ethylene SCHEMBL22615238 | 0.80 | HTT (0.64) | KMT2AHTTTSHRALDH1A1KDM4E | |
| SCHEMBL4675517 | 0.79 | HTT (0.58) | KMT2AHTTTSHRALDH1A1KDM4E | |
| SCHEMBL1179297 | 0.79 | KMT2A (0.54) | KMT2AHTTTSHRGLAALDH1A1 | |
| SCHEMBL362159 | 0.79 | TSHR (0.63) | KMT2ATSHRGLAALDH1A1HSD17B10 | |
| SCHEMBL13753395 | 0.79 | ALDH1A1 (0.67) | KMT2AHTTTSHRALDH1A1KDM4E | |
| SCHEMBL8121320 | 0.79 | ALDH1A1 (0.58) | KMT2AHTTTSHRALDH1A1HSD17B10 | |
| SCHEMBL28024073 | 0.79 | KMT2A (0.54) | KMT2AHTTTSHRGLAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 633 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119410225-A | High-wear-resistance seamless steel pipe material and preparation method thereof | 江苏玖骏钢管科技有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-112939829-B | Synthetic method of aryl trifluoromethyl thioether | 武汉药明康德新药开发有限公司 | 2023-02-21 | — | — | CN | claimed |
| CN-114044905-B | Preparation method of end-group functionalized polydimethylsiloxane | 复旦大学 | 2023-01-06 | — | — | CN | claimed |
| CN-114044905-A | Preparation method of end group functionalized polydimethylsiloxane | 复旦大学 | 2022-02-15 | — | — | CN | claimed |
| CN-112939829-A | Synthetic method of aryl trifluoromethyl thioether | 武汉药明康德新药开发有限公司 | 2021-06-11 | — | — | CN | claimed |
| CN-109734689-A | A method of furandicarboxylic acid is prepared using cuprous halide salt | 河南中医药大学 | 2019-05-10 | — | — | CN | claimed |
| CN-102675297-B | Preparation method of Lapatinib | Ren Fu Pharmaceutical Group stock company (CN) | 2014-10-15 | — | — | CN | claimed |
| CN-102675297-A | Preparation method of Lapatinib | WUHAN HUMANWELL HEALTHCARE GROUP CO LTD | 2012-09-19 | — | — | CN | claimed |
| US-20260076962-A1 | LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS | NIMMUNE BIOPHARMA, INC. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260062426-A1 | CYCLIN DEPENDENT KINASE DEGRADERS AND METHODS OF USE THEREOF | DIFFERENTIATED THERAPEUTICS INC (US) | 2026-03-05 | — | — | US | disclosed |
| US-12522618-B2 | Copper complexes for treatment of neurodegenerative disorders | ALS THERAPY DEVELOPMENT INSTITUTE (US) | 2026-01-13 | — | — | US | disclosed |
| EP-4673449-A1 | CYCLIN DEPENDENT KINASE DEGRADERS AND METHODS OF USE THEREOF | Differentiated Therapeutics Inc (US) | 2026-01-07 | — | — | EP | disclosed |
| US-12502388-B2 | Lanthionine synthetase C-like 2-based therapeutics | NIMMUNE BIOPHARMA, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250361244-A1 | BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS | AURIGENE ONCOLOGY LTD (IN) | 2025-11-27 | — | — | US | disclosed |
| US-4990518-A | Platelet activating factor | G. D. SEARLE & CO. (US) | 1991-02-05 | — | — | US | disclosed |
| US-4983619-A | Leukotriene antagonists | LILLY INDUSTRIES LIMITED (GB) | 1991-01-08 | — | — | US | disclosed |
| EP-0322164-A2 | Ethanolamine derivatives | GLAXO GROUP LIMITED (GB) | 1989-06-28 | — | — | EP | disclosed |
| CN-87105515-A | Derivatives of phenylbutenamide compounds and preparation method thereof | — | 1988-03-23 | — | — | CN | disclosed |
| EP-0259972-A2 | Heterocyclic propene amide derivatives, processes for their preparation and their use as pharmaceuticals | LILLY INDUSTRIES LIMITED (GB) | 1988-03-16 | — | — | EP | disclosed |
| US-4282246-A | Antidiabetic furancarboxylic and thiphenecarboxylic acids | PFIZER INC. (US) | 1981-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12502388-B2 | Lanthionine synthetase C-like 2-based therapeutics | LANCL2, CBS, LCP2 | KMT2A 2759/4885HTT 3949/4885TSHR 1860/4885 |
| US-20260062426-A1 | CYCLIN DEPENDENT KINASE DEGRADERS AND METHODS OF USE THEREOF | CCNA1, CCNE1, CCNA2 | KMT2A 777/4885HTT 3503/4885TSHR 358/4885 |
| US-20260076962-A1 | LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS | SCLY, CLCN2, CBS | KMT2A 2706/4885HTT 4272/4885TSHR 869/4885 |
| US-20250361244-A1 | BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS | IRAK4, IRAK3, IRAK1 | KMT2A 481/4885HTT 4240/4885TSHR 4307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.